ANAVEX LIFE SCIENCES CORP COMMON (AVXL) Covered Calls

Anavex Life Sciences Corporation is engaged in the discovery and development of novel drug targets for the treatment of cancer and diseases of the central nervous system.

You can sell covered calls on ANAVEX LIFE SCIENCES CORP COMMON to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AVXL (prices last updated Fri 4:16 PM ET):

ANAVEX LIFE SCIENCES CORP COMMON (AVXL) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
2.57 +0.02 2.52 2.58 223K - 0.1B
Covered Calls For ANAVEX LIFE SCIENCES CORP COMMON (AVXL)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 15 2.5 0.20 2.38 5.0% 62.9%
Jul 20 2.5 0.30 2.28 9.6% 54.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Anavex Life Sciences Corp. is a biopharmaceutical company. It is engaged in the discovery and development of new drugs for the treatment of neurological diseases and cancer, utilizing its proprietary drug discovery sigmaceptor platform. The company's portfolio comprises novel, wholly owned sigma receptor agonists and antagonists. Anavex Life Sciences was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.